Log in

OTCMKTS:ASDNAstro Aerospace Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/25/2020 04:00 PM ET)
Today's Range
Now: $0.07
50-Day Range
MA: $0.07
52-Week Range
Now: $0.07
Volume140,107 shs
Average Volume252,622 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Astro Aerospace Ltd. and its subsidiaries develop selfpiloted and autonomous, manned and unmanned, electric vertical take off and landing aerial vehicles. The company intends to provide the market with aerial transportation for humans and cargo. The company was formerly known as CPSM, Inc. and changed its name to Astro Aerospace Ltd. in March 2018. Astro Aerospace Ltd. is headquartered in Lewisville, Texas.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.68 out of 5 stars

Industry, Sector and Symbol

Industry Aerospace & Defense
Current SymbolOTCMKTS:ASDN



Sales & Book Value

Annual SalesN/A



Next Earnings Date6/22/2020 (Estimated)
OptionableNot Optionable

Receive ASDN News and Ratings via Email

Sign-up to receive the latest news and ratings for ASDN and its competitors with MarketBeat's FREE daily newsletter.

Astro Aerospace (OTCMKTS:ASDN) Frequently Asked Questions

How has Astro Aerospace's stock been impacted by COVID-19 (Coronavirus)?

Astro Aerospace's stock was trading at $0.1110 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ASDN stock has decreased by 41.4% and is now trading at $0.0650. View which stocks have been most impacted by Coronavirus.

When is Astro Aerospace's next earnings date?

Astro Aerospace is scheduled to release its next quarterly earnings announcement on Monday, June 22nd 2020. View our earnings forecast for Astro Aerospace.

Has Astro Aerospace been receiving favorable news coverage?

Media coverage about ASDN stock has trended very positive on Monday, according to InfoTrie. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Astro Aerospace earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news aboutAstro Aerospace.

Who are some of Astro Aerospace's key competitors?

What other stocks do shareholders of Astro Aerospace own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Astro Aerospace investors own include Allena Pharmaceuticals (ALNA), BioHiTech Global (BHTG), EnSync (ESNC), Agile Therapeutics (AGRX), Ampliphi Biosciences (APHB), Cronos Group (CRON), Okta (OKTA), Penn National Gaming (PENN), Sierra Oncology (SRRA) and Arbutus Biopharma (ABUS).

Who are Astro Aerospace's key executives?

Astro Aerospace's management team includes the following people:
  • Mr. Bruce Robert-Paul Bent, CEO, CFO, Controller & Director (Age 63)

What is Astro Aerospace's stock symbol?

Astro Aerospace trades on the OTCMKTS under the ticker symbol "ASDN."

How do I buy shares of Astro Aerospace?

Shares of ASDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Astro Aerospace's stock price today?

One share of ASDN stock can currently be purchased for approximately $0.07.

What is Astro Aerospace's official website?

The official website for Astro Aerospace is www.cpsm-inc.com.

How can I contact Astro Aerospace?

The company can be reached via phone at 972-221-1199.

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.